I am a
Home I AM A Search Login

Papers of the Week

Papers: 12 Sep 2020 - 18 Sep 2020

Human Studies, Pharmacology/Drug Development

2020 Sep 10


Pharmacological insight into the activation of the human Neuropeptide FF2 receptor.


Talmont F, Veneziano R, Dietrich G, Moulédous L, Mollereau C, Zajac J-M
Peptides. 2020 Sep 10:170406.
PMID: 32920044.


The neuropeptide FF2 (NPFF) receptor, predominantly expressed in the central nervous system, plays an important role in the modulation of sensory input and opioid analgesia, as well as in locomotion, feeding, intestinal motility, reward, and the control of obesity. The NPFF receptor belongs to the RFamide peptide receptor family and to the G protein coupled receptor (GPCR) super family, but contrary to many other class A GPCRs, no 3D structure has been solved. Thus, it is essential to perform mutagenesis to gain information on the fine functioning of the NPFF receptor. In this study, we examined the role of aspartic acid (D) from the "D/ERY/F" motif found in the second intracellular loop (ICL2) and the role of the C-terminal end of the receptor in ligand binding and signal transduction. We found that mutation D3.49A does not impair binding capacities but inhibits G protein activation as well as adenylyl cyclase regulation. Truncation of the C terminal part of the receptor has different effects depending on the position of truncation. When truncation was realized downstream of the putative acylation site, ligand binding and signal transduction capabilities were not lost, contrary to total deletion of the C terminus, which totally impairs the activity of the receptor.